Paracetamol pain relief works via TRPA1
Nature Communications
November 24, 2011
Paracetamol metabolites and a particular cannabinoid activate a channel protein called TRPA1 to mediate pain relief. This finding, reported in Nature Communications this week, suggests that identification of other agents that activate this channel may be useful analgesics. Using mice that lack TRPA1, Edward Hogestatt and colleagues demonstrated that this protein is required to mediate the analgesic properties of acetaminophenl, also known as paracetmaol. The authors showed that the metabolites of paracetamol activate the channel, and they could identify the presence of one of these metabolites in the mouse spinal cord, suggesting that this is the site of TRPA1 activation that is responsible for pain relief. They demonstrated that a cannabinoid derivative, Δ9-tetrahydrocannabiorcol which is known to activate TRPA1, also had an analgesic effect in the mouse, suggesting that the use of this compound or other agents that do not cause toxicity like paracetamol, may be useful for the treatment of pain.
doi: 10.1038/ncomms1559
Research highlights
-
Jun 29
COVID-19: Assessing instances of long COVID in UK health dataNature Communications
-
Jun 24
Palaeontology: It sucked to be the prey of ancient cephalopodsScientific Reports
-
Jun 24
Sport science: New wearable sensor to measure neck strain may detect potential concussionScientific Reports
-
Jun 23
Scientific community: Women credited less than men in scientific paper authorshipNature
-
Jun 17
Health technology: New cost-effective smartphone test for middle ear functionCommunications Medicine
-
Jun 17
Conservation: Feral cats pushing critically endangered marsupial further towards extinctionScientific Reports